Jaraa'idJaraa'id
Notification Show More
Latest News
European ammunition maker says plant expansion hit by energy-guzzling TikTok site
Business
Robin van Persie tipping ‘champion team’ Arsenal to end 19-year wait and win Premier League
Sports
Netanyahu sacks defence minister over refusal to back judicial reform
Business
Miami Open 2023: Bianca Andreescu marches on with win over Sofia Kenin, Belinda Bencic becomes latest big name to fall
Sports
US Vice President Kamala Harris in Africa to boost ties
Africa
Aa
  • Home
  • Local News
  • Africa
  • United States
  • Europe
  • Asia
  • Sports
  • Videos
  • Live Score
  • More
    • Business
    • Market Data
      • Stocks
      • Commodities
      • Cryptocurrency
      • Forex
    • Weather
Reading: Gap between EU & US on pharmaceutical investments too wide – industry
Share
Aa
Jaraa'idJaraa'id
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Business
  • Sports
  • Videos
Search
  • Home
  • Local News
  • Videos
  • World
    • Africa
    • United States
    • Europe
    • Asia
  • Market Data
    • Stocks
    • Commodities
    • Cryptocurrency
    • Forex
  • More
    • Sports
    • Business
    • Weather
    • Live Score
Have an existing account? Sign In
Follow US
Jaraa'id > Europe > Gap between EU & US on pharmaceutical investments too wide – industry
Europe

Gap between EU & US on pharmaceutical investments too wide – industry

News Room
Last updated: 2023/03/10 at 9:15 AM
News Room Published March 10, 2023
Share
SHARE

The gap in pharmaceutical investments between the European Union and the United States is widening by too much, according to the industry.

The sector is concerned that the difference between the EU and its American and Asian competitors, in terms of investment and access to the latest treatments, is becoming too big, and if it continues at this rate will be unbridgeable.

At the end of March, the European Commission will present its revision plans to the EU’s general pharmaceuticals legislation, in what will be an update to a 20-year-old text.

It is in this area that the pharmaceutical industry is stepping up its lobbying efforts to influence the Commission’s final proposals.

Part of their action plan has already been visible in the heart of the European quarter in Brussels, with an advertising campaign explaining the gap in investments littered on posters throughout the area.

“There are some significant gaps. The investment gap between the US and the EU 20 years ago was €2 billion, and now it’s €25 billion,” Nathalie Moll, Director General of the European Federation of Pharmaceutical Industries and Associations told Euronews.

“That’s a 1,000% increase in the gap and that’s very worrying if that trend continues and we want to stop it and reverse it.”

It is for this reason that the pharmaceutical industry is taking an alarming view of the Commission’s current draft text.

Moll says that 25 years ago, 50% of new treatments came from Europe, with one in five new treatments now coming from Europe, posing a serious threat to employment and competitiveness in Europe.

Virginia Acha, who works on global regulatory policy at Merck Sharp and Dohme, says it is worrying to see that companies are beginning to transfer some of their activities outside of Europe.

“In recent years we’ve seen unfortunately a move of clinical research to other parts of the world,” Acha told Euronews.

“We’ve seen investments moving again to the US and other parts of the world. The US has taken what used to be Europe’s leading advantage in biotechnology and now it’s in the US and we’d like to see Europe reclaim that role.”

One thing that the pharmaceutical companies do have in their favour is their economic weight. The sector is worth €43 billion per year when it comes to research and development and directly employs 840,000 people, supporting 2.5 million jobs in the EU.

Inevitably, this allows them to flex their muscles, so to speak.

For the moment though, the Commission is seemingly not phased, plodding on with its revision of the EU general pharmaceuticals legislation.

Its response to questions is that the aim of the reform is “to strike the right balance between promoting innovation and ensuring access to affordable medicines across the EU”.

Read the full article here

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room March 10, 2023
Share this Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
Business

European ammunition maker says plant expansion hit by energy-guzzling TikTok site

News Room News Room March 26, 2023
Robin van Persie tipping ‘champion team’ Arsenal to end 19-year wait and win Premier League
Netanyahu sacks defence minister over refusal to back judicial reform
Miami Open 2023: Bianca Andreescu marches on with win over Sofia Kenin, Belinda Bencic becomes latest big name to fall
US Vice President Kamala Harris in Africa to boost ties
The News Puzzle: test your knowledge of this month’s events
Jude Bellingham says he will ‘wait his turn’ for the England captaincy following fine display against Ukraine
Actor Jonathan Majors arrested in New York on assault charges
- Advertisement -
Ad imageAd image

You Might also Like

Europe

Brussels my love? The Putin-Xi bromance & the EU’s banking environment

March 25, 2023
Europe

State of the Union: Credit Suisse lifeline and Putin rolls out the red carpet for Xi

March 24, 2023
Europe

EU leaders insist eurozone is ‘resilient’ and ‘in good shape’ as Deutsche Bank shares plunge

March 24, 2023
Europe

Watch: How do EU Council summits work? Here’s a behind-the-scene sneak peek

March 24, 2023
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Cryptocurrency
  • Forex
  • Stock Market

About US

Jaraa'id is your one-stop website for the latest global and local news and updates, follow us now to get the news that matters to you.
Quick Link
  • Privacy Policy
  • Terms of use
  • Press ReleaseSubmit
  • Advertise
  • Contact
Top Sections
  • Business
  • Sports
  • Videos
  • Market DataLive
  • Weather

Subscribe US

Subscribe to our newsletter to get our Latest articles instantly!

I have read and agree to the terms & conditions

2023 © Jaraa'id. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?